Lobe Sciences Ltd.
LOBEF
$0.0407
$0.004813.37%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 0.00 | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 0.00 | -- |
| Cost of Revenue | -- | -- | -- | 11.20K | -171.60K |
| Gross Profit | -- | -- | -- | -11.20K | 171.60K |
| SG&A Expenses | 548.20K | 434.20K | 461.20K | 283.70K | 280.50K |
| Depreciation & Amortization | -- | -- | -- | 0.00 | 20.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 748.40K | 443.20K | 466.70K | 295.70K | 261.60K |
| Operating Income | -748.40K | -443.20K | -466.70K | -295.70K | -261.60K |
| Income Before Tax | -807.10K | -491.30K | -582.00K | -2.04M | -313.20K |
| Income Tax Expenses | -- | -- | -- | 24.10K | -- |
| Earnings from Continuing Operations | -807.10K | -491.30K | -582.00K | -2.07M | -313.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 107.00K | -- | -- | -- | -- |
| Net Income | -700.10K | -491.30K | -582.00K | -2.07M | -313.20K |
| EBIT | -748.40K | -443.20K | -466.70K | -295.70K | -261.60K |
| EBITDA | -733.30K | -428.40K | -451.30K | -295.70K | -240.90K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 192.76M | 186.37M | 173.70M | 170.91M | 114.29M |
| Average Diluted Shares Outstanding | 192.76M | 186.37M | 173.70M | 170.91M | 114.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |